Categories AlphaGraphs, Earnings, Health Care

Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues

Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The results also exceeded Wall Street’s projection.

AbbVie Q3 2021 earnings infographic

At $3.33 per share, September-quarter adjusted earnings were higher than $2.83 per share reported in the prior-year quarter and slightly above the consensus estimates. Net income, including special items, was $3.18 billion or $1.78 per share, compared to $2.31 billion or $1.29 per share in the third quarter of 2020.

Driving the bottom-line growth, net revenues increased 11% year-over-year to $14.34 billion. Market watchers were looking for slightly slower growth.


Read management/analysts’ comments on AbbVie’s Q3 results


AbbVie’s shares made modest gains on Friday morning following the earnings announcement, after closing the previous session higher.

Prior Performance

  • Abbvie Q3 2020 earnings

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

American Express (AXP) Q2 2025 Earnings: Key financials and quarterly highlights

American Express Company (NYSE: AXP) reported its second quarter 2025 earnings results today. Consolidated total revenues, net of interest expense, were $17.9 billion, up 9% year-over-year, driven by increased Card

Netflix Q2 earnings jump on strong revenue growth; results beat estimates

Video streaming giant Netflix, Inc. (NASDAQ: NFLX) reported a sharp increase in revenue and profit for the second quarter of fiscal 2025. The numbers also beat analysts' estimates. The company's

Tesla Q2 Earnings Preview: Can energy gains offset EV demand Slump?

For Tesla Inc. (NASDAQ: TSLA), the new fiscal year has been quite challenging, with first-quarter sales falling to a three-year low amid production issues related to Model Y and increasing

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top